SEMA3F and osteosarcoma: SEMA3F has been reported to function as a tumour suppressor inhibiting tumour growth and invasion in a number of cancer types, including lung, prostate, bladder, osteosarcoma, ovarian cancer, and melanoma cancer [3, 7, 12, 13, 24].